Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Journal of Gynecologic Oncology|July 7, 2026
Performance of multi-parameter differential diagnostic models for ovarian cancer screening in women with adnexal massesNingtao Cheng, Mengyan Tu, Chenchun Zhang, et al.Research (Washington, D.C.)|March 17, 2023
Nanoengineered Gallium Ion Incorporated Formulation for Safe and Efficient Reversal of PARP Inhibition and Platinum Resistance in Ovarian CancerYangyang Li, Yixuan Cen, Mengyan Tu, et al.Cancer Letters|May 7, 2024
Single-cell transcriptomics reveals the aggressive landscape of high-grade serous carcinoma and therapeutic targets in tumor microenvironmentJunfen Xu, Weiguo Lu, Xinyi Wei, et al.International Journal of Biological Sciences|May 6, 2026
CAF-derived exosomal circMPP6 drives ovarian cancer metastasis by coordinating nuclear and cytoplasmic regulation of ADAM22 to activate TGF-β/Smad signalingXinyi Wei, Xin Chen, Yan Ren, et al.Ebiomedicine|April 19, 2026
Proteomic profiling and molecular reclassification of high-grade serous ovarian cancer identifies prognostic subtypes and immunotherapy biomarkersMengyan Tu, Sangsang Tang, Qiao Zhang, et al.Aging|July 30, 2021
CircSPIDR acts as a tumour suppressor in cervical adenocarcinoma by sponging miR-431-5p and regulating SORCS1 and CUBN expressionJunfen Xu, Weiguo LuInternational Journal of Oncology|July 7, 2020
FAM83A exerts tumor‑suppressive roles in cervical cancer by regulating integrinsJunfen Xu, Weiguo LuWorld Journal of Surgical Oncology|October 21, 2024
Impact of PARP inhibitors on progression-free survival in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective analysisYumei Zhou, Junfen XuDiscover Oncology|March 9, 2025
Advances in S100 protein family for gynecological malignanciesShenglong Wu, Junfen XuPageof 8